← Back to patent-cliff list
R-Ketamine Hydrochloride Nasal Spray(Sichuan Purity Pharma)
Tier C — Watch / tradeR-Ketamine Hydrochloride Nasal Spray(Sichuan Purity Pharma)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NMDAR
Indications (approved)：Depressive disorder, Treatment-resistant depression
Regional status
US
-
EU
-
China
Phase II
2025-05-27
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of R-Ketamine Hydrochloride Nasal Spray(Sichuan Purity Pharma)?
Approved indications include: Depressive disorder, Treatment-resistant depression.
When does the R-Ketamine Hydrochloride Nasal Spray(Sichuan Purity Pharma) patent expire?
No public expiry year is available for R-Ketamine Hydrochloride Nasal Spray(Sichuan Purity Pharma) yet; this page updates once verified.
How do I get a quote for R-Ketamine Hydrochloride Nasal Spray(Sichuan Purity Pharma) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30